Pharmaceutical Product Development’s $550 Million Recapitalization With Existing Owners and New Investors

Simpson Thacher is representing Hellman & Friedman in connection with its entering into definitive agreements to recapitalize Pharmaceutical Product Development, LLC Under the agreements, Hellman &...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Tender offers by Micron Technology, Inc. to purchase its 5.625% Senior Notes due 2026 and 5.5% Senior Notes due 2025

Simpson Thacher represented Credit Suisse Securities (USA) LLC and J.P. Morgan Securities LLC, as dealer managers, in connection with the tender offers by Micron Technology, Inc....

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Virtusa’s $108 Million Strategic Equity Investment Agreement with The Orogen Group

Goodwin’s Technology team represented Virtusa Corporation in its investment agreement under which The Orogen Group will purchase shares of Virtusa’s newly issued convertible preferred stock, initially...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here